| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |